Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Immunocore Holdings Limited

Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore presented two posters at CROI 2024
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore Prices Upsized Convertible Senior Notes Offering
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore Announces Proposed Convertible Senior Notes Offering
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore announces upcoming presentation and posters at ESMO 2023
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to report second quarter 2023 financial results and host call on August 10, 2023
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present at the Bank of America Securities 2023 Health Care Conference
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present four posters at AACR Annual Meeting 2023
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore Reports 2022 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.